Gonadotropin-releasing Hormone (GnRH) Antagonist During 3 Days

• Status: Completed
• Trial end date: 2010-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

In this prospective study, the investigators would like to show whether ovarian stimulation with pretreatment of a GnRH antagonist during 3 consecutive days at initiation of the cycle, is possible.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Universitair Ziekenhuis Brussel

Criteria

Inclusion Criteria:

• < 39 years old on day of randomisation

• FSH < 12 (in the early follicular phase)

• Normal ultrasound scan, i.e. presence of both ovaries, without evidence of abnormality within 6 months prior to randomisation.

• Regular menstrual cycles of 21-35 days, presumed to be ovulatory.

• BMI between 18 and 29 (both inclusive)

• 1st or 2nd trial

• IVF or ICSI

• Randomisation at out-patient clinic

Exclusion Criteria:

• ≥ 39 years old on day of randomisation

• Endometriosis ≥ grade 3

• PCOS